Senhwa Biosciences, Inc. (TPEX:6492)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
38.95
+0.15 (0.39%)
Apr 2, 2025, 1:30 PM CST

Senhwa Biosciences Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
1110.550.62
Upgrade
Revenue Growth (YoY)
--81.82%-10.86%105.67%
Upgrade
Cost of Revenue
0.520.450.50.230.27
Upgrade
Gross Profit
0.480.550.510.320.35
Upgrade
Selling, General & Admin
62.9354.7943.7771.1783.24
Upgrade
Research & Development
243.74256.87312.85275.47276.37
Upgrade
Operating Expenses
306.67311.66356.62346.64359.61
Upgrade
Operating Income
-306.19-311.11-356.12-346.32-359.26
Upgrade
Interest Expense
-0.66-0.54-0.54-0.53-0.26
Upgrade
Interest & Investment Income
6.117.647.324.614.02
Upgrade
Currency Exchange Gain (Loss)
-1.190.49-11.240.43
Upgrade
Other Non Operating Income (Expenses)
0.8-0.010.920.2
Upgrade
EBT Excluding Unusual Items
-301.14-303.52-350.34-340.06-354.87
Upgrade
Gain (Loss) on Sale of Investments
8.688.042.081.520.49
Upgrade
Other Unusual Items
-0.43-10.2-
Upgrade
Pretax Income
-292.46-295.05-348.26-328.35-354.38
Upgrade
Income Tax Expense
1.281.261.370.910.5
Upgrade
Net Income
-293.75-296.31-349.63-329.26-354.88
Upgrade
Net Income to Common
-293.75-296.31-349.63-329.26-354.88
Upgrade
Shares Outstanding (Basic)
8989899079
Upgrade
Shares Outstanding (Diluted)
8989899079
Upgrade
Shares Change (YoY)
--0.00%-0.50%13.49%6.06%
Upgrade
EPS (Basic)
-3.29-3.32-3.92-3.67-4.49
Upgrade
EPS (Diluted)
-3.29-3.32-3.92-3.67-4.49
Upgrade
Free Cash Flow
-296.17-299-400.34-300.29-273.07
Upgrade
Free Cash Flow Per Share
-3.32-3.35-4.49-3.35-3.46
Upgrade
Gross Margin
47.70%55.20%50.50%58.73%56.89%
Upgrade
Operating Margin
-30619.10%-31111.10%-35611.50%-62966.54%-58226.74%
Upgrade
Profit Margin
-29374.50%-29630.60%-34963.20%-59864.91%-57516.69%
Upgrade
Free Cash Flow Margin
-29617.30%-29900.10%-40034.00%-54597.64%-44257.86%
Upgrade
EBITDA
-303.94-309.53-355.81-345.86-357.94
Upgrade
D&A For EBITDA
2.251.580.310.461.32
Upgrade
EBIT
-306.19-311.11-356.12-346.32-359.26
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.